New Formula & New Presentation

For a New Phase... A Healthier Experience

Biofemin 2G

Bibliography

  • Stoll W. Phytotherapeutic agent affects atrophic vaginal epithelium. Double-blind study: Cimicifuga vs. an estrogen preparation [translated from German]. Therapeutikon. 1987;1:23 - 31.

  • Liske E, Hanggi W, Henneicke-Von Zepelin HH, et al. Physiological Investigation of a Unique Extract of Black Cohosh (Cimicifugae racemosaerhizoma): A 6-Month Clinical Study Demonstrates No Systemic Estrogenic Effect. J Womens Health Gend Based Med. 2002;11:163-174.

  • Einer-Jensen N, Zhao J, Andersen KP, et al. Cimicifuga and Melbosia lack oestrogenic effects in mice and rats. Maturitas. 1996;25:149 - 153.

  • Jacobson JS, Troxel AB, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol. 2001;19:2739 - 2745.

  •  Schulz V, Hansel R, Tyler VE. Rational Phytotherapy: A Physicians' Guide to Herbal Medicine. 3rd ed. Berlin, Germany: Springer-Verlag; 1998:246.

  • Warnecke G. Influencing menopausal symptoms with a phytotherapeutic agent [in German]. Med Welt. 1985;36:871 - 874.

  • Stolze H. An alternative to treat menopausal complaints [translated from German]. Gyne. 1982;1:14 - 16.

  • Lehmann-Willenbrock E, Riedel HH. Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa [in German; English abstract]. Zentralbl Gynakol. 1988;110: 611 - 618.

  •   Liske E. Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders. AdvTher. 1998;15:45 - 53.

  • .MacLennan A, Lester S, Moore V. Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric. 2001;4:58 - 74.

  • Seidlova-Wuttke D, Wuttke W. Selective estrogen receptor modulator activity of Cimicifuga racemosa extract: clinical data [abstract]. Phytomedicine. 2000;7(suppl 2):11.

  • Seidlova-Wuttke D, Jarry H, Heiden I, et al. Effects of Cimicifuga racemosa on estrogen-dependent tissues [abstract]. Phytomedicine. 2000;7(suppl 2):11.

  • Seidlova-Wuttke D, Jarry H, Heiden I, et al. Selective estrogen receptor modulator (SERM) activity of the Cimicifuga racemosa extract BNO 1055: pharmacology and mechanisms of action [abstract]. Phytomedicine. 2000;7(suppl 2):12.

  • Jones TK, Lawson BM. Profound neonatal congestive heart failure caused by maternal consumption of blue cohosh herbal medication. J Pediatr. 1998;132:550 - 552.

  • Korn WD. Six-month Oral Toxicity Study with Remifemin-granulate in Rats Followed by an 8-week Recovery Period. Hannover, Germany: International Bio-research; 1991.

  • Nesselhut T, Schellhase C, Dietrich R, et al. Investigation into the growth-inhibitive efficacy of phytopharmacopia with estrogen-like influences on mammary gland carcinoma cells [translated from German]. Arch Gynecol Obstet. 1993;254:817 - 818.

  •  Zava DT, Dollbaum CM, Blen M. Estrogen and progestin bioactivity of foods, herbs and spices. Proc Soc Exp Biol Med. 1998;217:369 - 378.

More Information

» Biofemin 2G
» Clinical Information and Pharmacology
» Mechanisms of Action
» Pharmacokinetics and Pharmacodynamics
» Indications
» Dosage
» Clinical Studies
» Bibliography
» Exclusively For Doctors